Silk Road Medical (NASDAQ:SILK – Free Report) had its price target cut by Piper Sandler from $25.00 to $11.00 in a research report sent to investors on Wednesday, Benzinga reports. They currently have a neutral rating on the stock. Several other research analysts have also weighed in on the company. Stifel Nicolaus lowered Silk Road […]